Dan is an accomplished senior executive with comprehensive biotech, pharma, nutraceutical and agtech experience. He most recently led Kaydence Pharma, a development-stage pharmaceuticals company, and prior to that served as CEO of its former parent company, NattoPharma ASA. Beforehand, Dan spent nearly twenty years at FMC Corporation, in both the AG Products Group and Health & Nutrition division which focused on functional ingredients serving food, beverage, pharmaceutical and nutraceutical segments. Dan's tenure at FMC culminated in the role of general manager for FMC's pharmaceuticals ingredients and nutraceuticals divisions.
Dan’s C-suite experience includes stints as CEO, COO, and CFO in the U.S. and abroad, and has experience with everything from large corporate P&L’s to startups. He has extensive experience in areas of strategic planning, financial management, business turnarounds, acquisitions and integration.
Dan holds an MBA from Dartmouth’s Tuck School of Business Administration and twin BAs in Economics and Fine Arts from Cornell.
He is based in the Philadelphia area. He currently serves on the board of the Bicycle Coalition of Greater Philadelphia.
Education & Professional Certifications
- MBA, The Tuck School at Dartmouth
- BA in Economics, BFA in Sculpture; Cornell University
Areas of Expertise
- Business turnaround and restructuring
- Financial Management
- Forecasting & Planning
- Management Reporting & KPIs
- Mergers & Acquisitions
- Strategic Planning
- Supply Chain
- Early Stage Biotech
- Pharmaceutical and Food Ingredients
- Ag Tech
- Specialty Chemicals
- Kaydence Pharma
- NATTOPHARMA ASA